ciprofloxacin has been researched along with Infarct in 1 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, C | 1 |
| Cheng, X | 1 |
| Zhong, S | 1 |
| Liu, Z | 1 |
| Liu, F | 1 |
| Lin, X | 1 |
| Zhao, Y | 1 |
| Guan, M | 1 |
| Xiao, T | 1 |
| Jolkkonen, J | 1 |
| Wang, Y | 1 |
| Zhao, C | 1 |
1 other study available for ciprofloxacin and Infarct
| Article | Year |
|---|---|
Long-term modification of gut microbiota by broad-spectrum antibiotics improves stroke outcome in rats.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Ciprofloxacin; Cytokines; Endothelin-1; Fatty Acids, Vol | 2022 |